Dayvigo 62856-0405
Generic: Lemborexant
Product NDC
62856-0405- Manufacturer
- Eisai Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- April 7, 2020
- Listing Expires
- December 31, 2026
- Application
- NDA212028
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lemborexant | 5 mg/1 |
Drug Class
Orexin Receptor Antagonist [EPC]Cytochrome P450 2B6 Inducers [MoA]Orexin Receptor Antagonist [EPC]
Packaging Options(3)
1 BLISTER PACK in 1 CARTON (62856-405-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK
30 TABLET, FILM COATED in 1 BOTTLE (62856-405-30)
90 TABLET, FILM COATED in 1 BOTTLE (62856-405-90)